You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HL

Showing 26 - 50 of 6,399
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity Trial in Edinburgh (Adapted NHS weight management 1:1 programme, NHS 1:1 weight management programme)

Terminated
  • Obesity
  • Adapted NHS weight management 1:1 programme
  • NHS 1:1 weight management programme
  • Edinburgh, United Kingdom
    Astley Ainslie Hospital
Oct 19, 2022

Cartilage Disease Trial in London, Wakefield (BioPoly RS Partial Resurfacing Patella Implant)

Recruiting
  • Cartilage Disease
  • BioPoly RS Partial Resurfacing Patella Implant
  • London, England, United Kingdom
  • +1 more
Jul 18, 2022

Lymphoma, Lymphoma, Non-Hodgkin, Immune System Diseases Trial in Chapel Hill (ATLCAR.CD30 cells)

Recruiting
  • Lymphoma
  • +7 more
  • ATLCAR.CD30 cells
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Dec 2, 2022

Hodgkin Lymphoma Trial in Valhalla (Brentuximab Vedotin, Allogeneic Stem Cell Transplantation, Reduced Intensity Conditioning)

Active, not recruiting
  • Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +2 more
  • Valhalla, New York
    New York Medical College
Oct 24, 2022

Radiation-Induced Cardiac Injury in Hodgkin Lymphoma Treated

Completed
  • Hodgkin's Lymphoma
  • Cardiac Magnetic Resonance Imaging
  • Echocardiogram
  • Jacksonville, Florida
    University of Florida Health Proton Therapy Institute
Jun 9, 2022

Depressed Patients With Coronary Heart Disease - R01HL147862

Recruiting
  • Coronary Heart Disease
  • Depression
  • Other
  • Saint Louis, Missouri
    Washington University
Mar 30, 2022

Parkinson Disease Trial in Paris (Identification of COMT HH, COMT HL or COMT LL genes, Brain MRI with resting state scan, Brain

Completed
  • Parkinson Disease
  • Identification of COMT HH, COMT HL or COMT LL genes
  • +2 more
  • Paris, France
    Groupe Hospitalier Pitié-Salpêtrière
Feb 17, 2022

Relapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin Lymphoma Trial in Seoul

Completed
  • Relapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin Lymphoma
    • Seoul, Gangnam-Gu, Korea, Republic of
      Samsung Medical Center
    Feb 4, 2022

    Knee Osteoarthritis Trial in Worldwide (HL-01: high and low molecular weight hyaluronic acid, Placebo)

    Completed
    • Knee Osteoarthritis
    • HL-01: high and low molecular weight hyaluronic acid
    • Placebo
    • Liège, Belgium
    • +30 more
    Nov 15, 2021

    Solid Tumor, Adult Trial in United States (HL-085)

    Recruiting
    • Solid Tumor, Adult
    • San Marcos, California
    • +4 more
    Mar 17, 2021

    Dry Eye Trial in Xiamen (HBM9036 0.25% Ophthalmic Solution, Placebo)

    Recruiting
    • Dry Eye
    • HBM9036 0.25% Ophthalmic Solution
    • Placebo
    • Xiamen, Fujian, China
      Xiamen Eye Center of Xiamen University
    Jun 16, 2022

    Caprini Score in Venous Surgery: a Prospective Cohort Study

    Recruiting
    • Venous Thromboembolism
    • Varicose Veins
    • EVLT
    • +7 more
    • Moscow, Russian Federation
      Pirogov Russian National Research Medical University
    Feb 14, 2022

    Addison's Disease Trial in London (Solu-Cortef 100 MG Injection, Hydrocortisone 100mg/ml)

    Recruiting
    • Addison's Disease
    • Solu-Cortef 100 MG Injection
    • Hydrocortisone 100mg/ml
    • London, United Kingdom
      The London Clinic
    Apr 22, 2022

    Hodgkin Lymphoma Trial in Belgium, Denmark, Netherlands (gemcitabine, cisplatin and tislelizumab)

    Not yet recruiting
    • Hodgkin Lymphoma
    • gemcitabine, cisplatin and tislelizumab
    • Brussels, Belgium
    • +14 more
    Aug 12, 2022

    AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

    Recruiting
    • AML
    • +8 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    May 13, 2022

    Hodgkin Lymphoma, Adult, Relapsed Hodgkin's Disease, Adult, Refractory Hodgkin Lymphoma Trial in Caba (Evaluation of

    Recruiting
    • Hodgkin Lymphoma, Adult
    • +2 more
    • Evaluation of therapeutical approach after ASCT
    • Caba, Argentina
      FUNDALEU
    Oct 1, 2021

    Solid Tumor, Adult Trial in Austin, San Antonio (HL-085)

    Terminated
    • Solid Tumor, Adult
    • Austin, Texas
    • +1 more
    Nov 16, 2020

    Platelet-Rich Plasma Versus Mesotherapy in Androgenetic

    Not yet recruiting
    • Androgenetic Alopecia
    • +2 more
    • Platelet-rich plasma
    • Mesotherapy
    • (no location specified)
    Nov 11, 2021

    Healthy Chinese Volunteers Trial in Hong Kong (HBM9161(HL161BKN), Placebo)

    Completed
    • Healthy Chinese Volunteers
    • Hong Kong, China
      Queen Mary Hospital, Phase 1 Clinical Trials Centre
    Mar 9, 2021

    Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in United States (drug, other, biological)

    Active, not recruiting
    • Recurrent Hodgkin Lymphoma
    • Refractory Hodgkin Lymphoma
    • Duarte, California
    • +3 more
    Oct 24, 2022

    Women Undergoing Assisted Reproductive Technology Treatment

    Recruiting
    • Adenomyosis
    • +4 more
    • Ultrasound diagnosis of adenomyosis
    • Birmingham, England, United Kingdom
    • +5 more
    Oct 3, 2022

    Tobacco, Alcohol, Prescription Medication and Other

    Recruiting
    • Substance Use
    • +2 more
    • TAPS
    • Boekel, Noord Brabant, Netherlands
    • +2 more
    Mar 4, 2022

    Rheumatoid Arthritis Trial in Seoul (HL237 tablet, Placebo of HL237 tablet)

    Enrolling by invitation
    • Rheumatoid Arthritis
    • HL237 tablet
    • Placebo of HL237 tablet
    • Seoul, Korea, Republic of
      The Catholic University of Korea Seoul ST.MARY'S Hospital
    Nov 16, 2020

    Healthy Male Volunteers Trial in Seoul (HL237 tablet, tacrolimus capsule)

    Active, not recruiting
    • Healthy Male Volunteers
    • HL237 tablet
    • tacrolimus capsule
    • Seoul, Korea, Republic of
      The Korea Univertisy Anam Hospital
    Nov 16, 2020

    Hodgkin Disease, Lymphoma, Large-Cell, Anaplastic Trial in China (Brentuximab Vedotin)

    Completed
    Has Results
    • Hodgkin Disease
    • Lymphoma, Large-Cell, Anaplastic
    • Brentuximab Vedotin
    • Beijing, Beijing, China
    • +6 more
    Feb 3, 2021